Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(24)
DRUG(5)
PROCEDURE(3)
peripheral blood stem cell transplantation
4 trials
phase_1_2phase_2
fred-hutchinson-cancer-center
fludarabine phosphate
3 trials
phase_1_2phase_2
fred-hutchinson-cancer-center
cyclosporine
3 trials
phase_1_2phase_2
fred-hutchinson-cancer-center
total-body irradiation
3 trials
phase_1_2phase_2
fred-hutchinson-cancer-center
mycophenolate mofetil
2 trials
phase_1_2phase_2
fred-hutchinson-cancer-center
nonmyeloablative allogeneic hematopoietic stem cell transplantation
2 trials
phase_1_2phase_2
fred-hutchinson-cancer-center
melphalan
2 trials
phase_1_2phase_2
fred-hutchinson-cancer-center
laboratory biomarker analysis
2 trials
phase_1_2phase_2
fred-hutchinson-cancer-center

+10 more interventions

18 unique interventions3 categories

Analytics

Trial Phases

Phase 11
Phase 24
Phase 31

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT00793572Phase 2Completed
Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
Refractory Plasma Cell Myeloma
PrincipalinvestigatorStart date: 2008-10-01
NCT00054353Phase 1/2Completed
Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
Refractory Multiple Myeloma
Principalinvestigator
NCT00929695Phase 3Completed
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
Graft Versus Host DiseaseRecurrent Adult Acute Lymphoblastic Leukemia
Principalinvestigator
NCT01427881Phase 2Completed
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Principalinvestigator
NCT01525407Phase 2Completed
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Malignant Neoplasm
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Graft vs Host DiseaseRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score2%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

CancerLeukemia, Myelomonocytic, ChronicRecurrent Adult Acute Myeloid Leukemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

CancerGraft vs Host Disease

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Graft vs Host DiseaseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score1%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaRefractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score1%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score0%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score0%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Cancer
Similarity Score0%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer
Similarity Score0%

Emily Y Chew, M.D.

National Eye Institute (NEI)

Related
17 trials

Shared therapeutic areas:

Cancer
Similarity Score0%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT00793572Phase 2PrincipalInvestigator

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma
Completed
NCT00054353Phase 1/2PrincipalInvestigator

Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Multiple Myeloma
Completed
NCT00929695Phase 3PrincipalInvestigator

Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease

Graft Versus Host DiseaseRecurrent Adult Acute Lymphoblastic Leukemia
Completed
NCT01427881Phase 2PrincipalInvestigator

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Completed
NCT01525407Phase 2PrincipalInvestigator

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Malignant Neoplasm
Completed

All 5 trials loaded